arrow_back Back to App

Increased Transparency in Medicare Drug Prices for Seniors

New rules aim to increase transparency in drug costs for seniors using Medicare. Pharmacy Benefit Managers (PBMs) will be required to disclose more information about prices and rebates, potentially leading to lower drug costs for patients. These changes will take effect from 2028.
Key points
Pharmacy Benefit Managers (PBMs) must disclose detailed information on drug prices, rebates, and other fees.
Medicare insurers will be able to audit PBMs to verify the accuracy of reported data.
PBMs will need to report on cost differences between brand-name drugs and their cheaper alternatives (generics and biosimilars).
The goal is to reduce drug costs for seniors by increasing market competition and transparency.
article Official text account_balance Process page
Introduced
Citizen Poll
No votes cast
Additional Information
Print number: 119_HR_950
Sponsor: Rep. Landsman, Greg [D-OH-1]
Process start date: 2025-02-04
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Saving Seniors Money on Prescriptions Act

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 119_HR_950.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2025-02-04.

What are the main provisions?

Key points include:

  • Pharmacy Benefit Managers (PBMs) must disclose detailed information on drug prices, rebates, and other fees.
  • Medicare insurers will be able to audit PBMs to verify the accuracy of reported data.
  • PBMs will need to report on cost differences between brand-name drugs and their cheaper alternatives (generics and biosimilars).
  • The goal is to reduce drug costs for seniors by increasing market competition and transparency.
What is the specific legal status?

The current status is Introduced.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Landsman, Greg [D-OH-1].

What is the latest detailed status?

The latest detailed status is: Introduced in House

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-23.

CATEGORIES

Health Benefits